These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 13632486)
1. [Neutralization of heparin with protamine sulfate after extracorporeal circulation with the artificial heart-lung apparatus]. GEMMA GB; CALUZZI F; MARGAGLIA F Minerva Chir; 1958 Dec; 13(23):1455-7. PubMed ID: 13632486 [No Abstract] [Full Text] [Related]
2. [Neutralization of heparin by protamine during interventions using extracorporeal circulation]. DUBOURG G; TRARIEUX M; FONTAN F; MOULINIER J; BRICAUD H; BROUSTET P Rev Fr Etud Clin Biol; 1960; 5():691-6. PubMed ID: 13724652 [No Abstract] [Full Text] [Related]
3. [ON THE CONTROL OF ADEQUATE HEPARIN NEUTRALIZATION BY PROTAMINE SULFATE DURING EXTRACORPOREAL CIRCULATION]. MARGULIS MS; BERZIN UIa Vestn Khir Im I I Grek; 1964 Nov; 93():16-22. PubMed ID: 14319691 [No Abstract] [Full Text] [Related]
10. EVALUATION OF PROTAMINE AND HEXADIMETHRINE BROMIDE AS ANTIHEPARIN AGENTS IN EXTRACORPOREAL CIRCULATION. GUPTA S; BANERJEE C; BASU AK J Indian Med Assoc; 1963 Sep; 41():231-6. PubMed ID: 14063345 [No Abstract] [Full Text] [Related]
11. [Heparin and protamine in extracorporeal circulation]. SATTER P Thoraxchirurgie; 1961 Feb; 8():499-503. PubMed ID: 13746734 [No Abstract] [Full Text] [Related]
12. [Evaluation of the heparin activity in the blood in the course of extracorporeal circulation in cardiosurgical operations]. TOMAI F; TUCCI G Ann Ital Chir; 1961 Jan; 38():43-56. PubMed ID: 13777278 [No Abstract] [Full Text] [Related]
13. [Impact of protamine sulfate on hemostasis system after operations with artificial circulation]. Charnaia MA; Klypa TV; Morozov IuA; Shmerko NP; Gladysheva VG; Andriianova AA Khirurgiia (Mosk); 2007; (8):17-20. PubMed ID: 17828120 [TBL] [Abstract][Full Text] [Related]
14. Strategies for improving the functionality of an affinity bioreactor. Wang T; Yang Z; Emregul E; David A; Balthasar JP; Liang J; Yang VC Int J Pharm; 2005 Dec; 306(1-2):132-41. PubMed ID: 16246511 [TBL] [Abstract][Full Text] [Related]
15. [Experimental extracorporeal circulation with the Kay-Cross artificial heart-lung apparatus]. DE RABAGO G; DE RABAGO P; URQUIA M; MEDINA H; ESQUIVEL A; SOKOLOWSKI M Rev Clin Esp; 1958 Dec; 71(5):303-12. PubMed ID: 13634526 [No Abstract] [Full Text] [Related]
16. [Physiology of extracorporeal circulation & oxygenation with the Dogliotti-Battezzati-Taddei artificial heart-lung apparatus. II]. BATTEZZATI M; TADDEI C; CATTANEO AD; GEMMA GB; BACHI V Minerva Chir; 1958 Dec; 13(23):1440-3. PubMed ID: 13632482 [No Abstract] [Full Text] [Related]
17. Use of the plasma thrombin time to assess the adequacy of in vivo neutralization of heparin: comparative studies following operations employing extracorporeal circulation. PEDEN JC; McFARLAND JA Blood; 1959 Nov; 14():1230-6. PubMed ID: 14431320 [No Abstract] [Full Text] [Related]
18. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate. Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496 [TBL] [Abstract][Full Text] [Related]
19. [Heparin content and thrombogenic blood proteins in the early postoperative period in patients operated on with artificial circulation]. Ishmukhametova DN; Dmitrieva VA; Liude MN; Tskhovredov SV Anesteziol Reanimatol; 1981; (5):56-8. PubMed ID: 7325387 [No Abstract] [Full Text] [Related]
20. [Experimental study on the state of circulating blood in the body under extracorporeal circulation and a re-examination of the heparin rebound phenomenon]. HAYASHI H; CHIBA C; TANAKA T; OSAWA M; SHIMIZU H; IWAMOTO A; HASHIMOTO A; MATSUMURA G Kyobu Geka; 1961 Jun; 14():564-75. PubMed ID: 13712444 [No Abstract] [Full Text] [Related] [Next] [New Search]